We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$232M
AUM Growth
+$7.64M
Cap. Flow
-$4.37M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.55%
Holding
143
New
2
Increased
Reduced
Closed
5

Top Buys

Rank Stock Value
1
LVS icon
Las Vegas Sands
LVS
+$2.35M
2
PE
PARSLEY ENERGY INC
PE
+$2.01M

Sector Composition

Rank Sector Weight
1 Technology 26%
2 Healthcare 18.84%
3 Consumer Discretionary 11.92%
4 Communication Services 9.64%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DISH
76
DELISTED
DISH Network Corp.
DISH
$1.42M 0.61%
29,711
CORT icon
77
Corcept Therapeutics
CORT
$10.2B
$1.41M 0.61%
78,194
IRWD icon
78
Ironwood Pharmaceuticals
IRWD
$611M
$1.4M 0.6%
111,449
PFBC icon
79
Preferred Bank
PFBC
$1.22B
$1.4M 0.6%
23,732
ATEN icon
80
A10 Networks
ATEN
$2.47B
$1.39M 0.6%
180,290
KNSL icon
81
Kinsale Capital Group
KNSL
$7.95B
$1.39M 0.6%
30,884
AMRC icon
82
Ameresco
AMRC
$1.15B
$1.37M 0.59%
159,376
VICR icon
83
Vicor
VICR
$9.62B
$1.36M 0.59%
65,131
NRC icon
84
NRC Health Common Stock
NRC
$474M
$1.34M 0.58%
36,065
HCKT icon
85
Hackett Group
HCKT
$245M
$1.34M 0.58%
85,382
IPAR icon
86
Interparfums
IPAR
$3.92B
$1.34M 0.58%
30,751
ISRG icon
87
Intuitive Surgical
ISRG
$121B
$1.33M 0.58%
10,962
OMCL icon
88
Omnicell
OMCL
$1.86B
$1.33M 0.57%
27,421
FORR icon
89
Forrester Research
FORR
$172M
$1.32M 0.57%
29,881
ENSG icon
90
The Ensign Group
ENSG
$10.1B
$1.32M 0.57%
63,480
STZ icon
91
Constellation Brands
STZ
$22.2B
$1.32M 0.57%
5,764
BF.B icon
92
Brown-Forman Class B
BF.B
$12B
$1.3M 0.56%
29,645
MKTX icon
93
MarketAxess Holdings
MKTX
$4.15B
$1.3M 0.56%
6,460
TSC
94
DELISTED
TriState Capital Holdings, Inc.
TSC
$1.29M 0.56%
56,037
DPLO
95
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.27M 0.55%
63,403
CSV icon
96
Carriage Services
CSV
$618M
$1.27M 0.55%
49,422
LOB icon
97
Live Oak Bancshares
LOB
$1.95B
$1.26M 0.55%
52,912
JUNO
98
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.26M 0.55%
27,602
PDFS icon
99
PDF Solutions
PDFS
$2.13B
$1.25M 0.54%
79,828
MNST icon
100
Monster Beverage
MNST
$91.4B
$1.23M 0.53%
38,982

Similar funds

Capital Impact Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Capital Impact Advisors held 143 positions worth $232M, up 3.4% from $224M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 4.9%. Capital Impact Advisors opened 2 new positions and exited 5, leaving the 143-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Impact Advisors's largest Q4 2017 buy was Las Vegas Sands: 35,180 shares worth $2.44M.
  • Capital Impact Advisors fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $2.32M.
  • Capital Impact Advisors's ten largest holdings make up 17% of its $232M portfolio in Q4 2017.
  • Capital Impact Advisors opened 2 new positions and closed 5 in Q4 2017.
  • Capital Impact Advisors's portfolio value rose 3.4% quarter-over-quarter to $232M.

Based on Capital Impact Advisors's 13F filing for Q4 2017, filed 16 Jan 2018.